Stock Events

Stock Events

Polaris AI Pharma 

₩5,350
1
+₩20+0.38% Friday 06:12

Statistics

Day High
5,350
Day Low
5,350
52W High
10,200
52W Low
4,110
Volume
-
Avg. Volume
-
Mkt Cap
71.06B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Apr 24
₩100
Apr 23
₩100
Apr 22
₩100
Apr 21
₩100
Apr 20
₩100
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

31DecExpected
Q1 2017
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
-9.92
126.8
263.53
400.25
Expected EPS
N/A
Actual EPS
126

Financials

11.09%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
55.54BRevenue
6.16BNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Seegene
096530.KQ
Mkt Cap1.3T
SillaJen, Inc. focuses on oncolytic virotherapy, an area of biotechnology that could overlap with therapeutic areas targeted by Polaris AI Pharma.
Celltrion Health Care
091990.KQ
Mkt Cap11.33T
Cellivery Therapeutics is involved in developing innovative drug delivery technologies, which could compete with Polaris AI Pharma's drug development strategies.
Genexine
095700.KQ
Mkt Cap103.47B
Genexine is engaged in the clinical development and commercialization of biologics, aligning closely with Polaris AI Pharma's core business.
Medy-Tox
086900.KQ
Mkt Cap471.87B
Medy-Tox operates in the biopharmaceutical sector, focusing on botulinum products and biologics that could compete with Polaris AI Pharma's offerings.
Sugentech Incorporate
253840.KQ
Mkt Cap57.79B
Alteogen is a biotech company that develops biosimilars and novel biologics, competing in the same innovative drug development space as Polaris AI Pharma.
Sillajen
215600.KQ
Mkt Cap286.62B
Seegene Inc specializes in molecular diagnostics, which complements and competes with the biopharmaceutical technologies developed by Polaris AI Pharma.
Access Bio
950130.KQ
Mkt Cap79.67B
JW Therapeutics focuses on cell therapy, particularly in the oncology sector, which might intersect with therapeutic areas pursued by Polaris AI Pharma.

About

EstechPharma Co., Ltd. manufactures and sells pharmaceuticals products. It also offers raw materials, such as RBM and PLK. The company was formerly known as Estech Chemical and changed its name to EstechPharma Co., Ltd. in January 2001. EstechPharma Co., Ltd. was founded in 1996 and is headquartered in Hwaseong-si, South Korea.
Show more...
CEO
Mr. Jae-Chul Kim
Employees
159
Country
South Korea
ISIN
KR7041910001

Listings

KQ
KR
041910.KQ

0 Comments

Share your thoughts

FAQ

What is Polaris AI Pharma stock price today?▼
The current price of 041910.KQ is ₩5,350 KRW — it has increased by +0.38% in the past 24 hours. Watch Polaris AI Pharma stock price performance more closely on the chart.
What is Polaris AI Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on KOSDAQ exchange Polaris AI Pharma stocks are traded under the ticker 041910.KQ.
Is Polaris AI Pharma stock price growing?▼
041910.KQ stock has fallen by -2.01% compared to the previous week, the month change is a -1.65% fall, over the last year Polaris AI Pharma has showed a -14.94% decrease.
What is Polaris AI Pharma market cap?▼
Today Polaris AI Pharma has the market capitalization of 71.06B
What were Polaris AI Pharma earnings last quarter?▼
041910.KQ earnings for the last quarter are 126 KRW per share, whereas the estimation was N/A KRW resulting in a N/A surprise. The estimated earnings for the next quarter are N/A KRW per share.
What is Polaris AI Pharma revenue for the last year?▼
Polaris AI Pharma revenue for the last year amounts to 55.54B KRW.
What is Polaris AI Pharma net income for the last year?▼
041910.KQ net income for the last year is 6.16B KRW.
Does Polaris AI Pharma pay dividends?▼
Yes, 041910.KQ dividends are paid annual. The last dividend per share was 100 KRW. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Polaris AI Pharma have?▼
As of September 06, 2026, the company has 159 employees.
In which sector is Polaris AI Pharma located?▼
Polaris AI Pharma operates in the Health & Wellness sector.
When did Polaris AI Pharma complete a stock split?▼
Polaris AI Pharma has not had any recent stock splits.
Where is Polaris AI Pharma headquartered?▼
Polaris AI Pharma is headquartered in Hwaseong-si, South Korea.